Second-generation antibody protects from SARS-CoV-2, its variant and prevents it from mutating to resist therapy
Tumor cells reveal a core syncytial drive to evade host defenses
25 January 2021Smoking killing one in three First Nations people
25 January 2021Second-generation antibody protects from SARS-CoV-2, its variant and prevents it from mutating to resist therapy
The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated with the Università della Svizzera italiana (USI) has developed a second-generation double antibody that protects against SARS-CoV-2, the virus that causes COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy.
